VitaNova Life Sciences (VNOV) EBIT Growth (1y) (2018 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 35.14% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 10.27% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -30.27% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 4.00% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -13.47% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -16.79% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 95.41% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -162.16% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -57.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -57.08% |
| Oct 31, 2025 | 58.42% |
| Jul 31, 2025 | 28.57% |
| Apr 30, 2025 | 365.12% |
| Jan 31, 2025 | 1,730.43% |
| Oct 31, 2024 | 815.02% |
| Jul 31, 2024 | -87.30% |
| Apr 30, 2024 | 5,406.34% |
| Jan 31, 2024 | 124.20% |
| Oct 31, 2023 | -436.60% |
| Jul 31, 2023 | -1,236.22% |
| Apr 30, 2023 | -326.38% |
| Jan 31, 2023 | -197.63% |
| Oct 31, 2022 | 108.67% |
| Jul 31, 2022 | 120.35% |
| Apr 30, 2022 | 126.92% |
| Jan 31, 2022 | 968.33% |
| Oct 31, 2021 | -142.16% |
| Jul 31, 2021 | 6.77% |
| Apr 30, 2021 | 72.68% |